Metyrapone for depression and delirium secondary to Cushing's syndrome.
D003480:Cushing Syndrome / Q000150:complications*; D003693:Delirium / Q000188:drug therapy*; D003866:Depressive Disorder / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008797:Metyrapone / Q000627:therapeutic use*; D008875:Middle Aged
D008797:Metyrapone